Request Deal Involvement
Oculis went public via a SPAC merger with European Biotech Acquisition in a $220m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Consilium Strategic Communications
financial advisors
Bank of America
legal advisors
Cooley
legal advisors
Vischer
financial advisors
Leerink Partners
accounting advisors
PricewaterhouseCoopers
financial advisors
Credit Suisse
legal advisors
Stibbe
financial advisors
Van Lanschot Kempen
legal advisors
Maples Group
financial advisors
Bank of America
financial advisors
Leerink Partners
legal advisors
Davis Polk & Wardwell
legal advisors to financial advisors
Shearman & Sterling
financial advisors
Arctica Finance
or
Principals
bidder
TEKLA CAPITAL MANAGEMENT LLC
bidder
VI PARTNERS
bidder
PIVOTAL BIOVENTURE PARTNERS LLC
bidder
NOVARTIS VENTURE FUND
target
OCULIS
bidder
EARLYBIRD VENTURE CAPITAL GMBH
bidder
EUROPEAN BIOTECH ACQUISITION CORP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite